On June 10, the FDA’s Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee voted 11-0, unanimously recommending approval of the Elie LillyLLY’s Alzheimer’s drug, donanemab....
Global obesity rates have almost tripled since 1975 and are expected to affect more than half the population by 2035, according to the WHO and Goldman...
Global obesity rates have almost tripled since 1975 and are expected to affect more than half the population by 2035, according to the WHO and Goldman...
